SMED‎ > ‎


T- CART, new albeit expensive cancer treatment
Sarmad Raheem Kareem
Koya University/ School of Medicine/

Abstract: Immunotherapy has been long tried in the treatment of several human diseases including cancer & Chimeric Antigen T cell Receptor is now successfully tried in some hematologic malignancies & some success for solid tumors but the cost & future complications are a persistent challenge.
Keywords: Cancer, T cells, Chimeric, Treatment

Date: 5/9/2018
PlaceSchool of Medicine/ Hall no.3
Caroline Yousif Daniel,
May 20, 2018, 6:20 AM